Standout Papers

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 c... 2007 2026 2013 2019 780
  1. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial (2007)
    Lu Zhang, Ferenc Martényi et al. Nature Medicine

Immediate Impact

4 by Nobel laureates 20 from Science/Nature 61 standout
Sub-graph 1 of 20

Citing Papers

Theranostic Fluorescent Probes
2024 Standout
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
2023 StandoutScience
3 intermediate papers

Works of A M Reznik being referenced

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
2007 Standout

Author Peers

Author Last Decade Papers Cites
A M Reznik 49 196 149 590 418 21 858
Andreev Bv 39 193 134 596 413 29 857
А С Аведисова 110 250 180 593 418 39 1.0k
Geoffrey Pavey 25 248 130 557 497 34 910
Dawn D. Han 76 169 60 718 455 16 965
Philipp Singer 25 161 143 629 416 36 1.1k
Masatomo Ishikawa 69 168 141 319 373 27 930
Elisabetta Filomena Buonaguro 102 323 173 412 317 39 967
Masahiro Nankai 100 204 115 496 312 25 921
Marie K. L. Nilsson 96 133 149 518 279 11 831
H. Shibuya 85 168 76 460 271 31 803

All Works

Loading papers...

Rankless by CCL
2026